Showing results (91-100 of 121) with videos related to
Sort By:
Pageof 13
International Journal of Cancer|September 15, 1987
Down-regulation of the EBV-encoded membrane protein (LMP) in Burkitt lymphomasA Hatzubai, M Anafi, M G Masucci, et al.International Journal of Cancer|November 15, 1987
Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte culturesJ Avila-Cariño, S Torsteinsdottir, B Ehlin-Henriksson, et al.Cellular Immunology|May 1, 1984
Production of leukocyte migration inhibitory factor (LIF) in human lymphocyte subsets exposed to polyclonal activatorsG Masucci, R Szigeti, D Stevens, et al.International Journal of Cancer|June 15, 1989
Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patientsG Masucci, H Mellstedt, G Henle, et al.International Journal of Cancer|April 1, 1993
Over-expression of C-myc increases the sensitivity of Epstein-Barr virus immortalized lymphoblastoid cells to non-MHC-restricted cytotoxicityL Cuomo, Q J Zhang, L Lombardi, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicityS Torsteinsdottir, M G Masucci, B Ehlin-Henriksson, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1992
Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphomaR Gavioli, P O De Campos-Lima, M G Kurilla, et al.European Journal of Cancer & Clinical Oncology|April 1, 1987
Analysis of Epstein-Barr virus-specific and non-specific immune functions in a patient during the development of a non-Hodgkin's lymphomaG Masucci, H Mellstedt, M G Masucci, et al.International Journal of Cancer|February 15, 1989
Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an IgH/myc translocation-carrying BL lineS Torsteinsdóttir, M L Andersson, J Avila-Cariño, et al.Biochemical and Biophysical Research Communications|January 5, 1995
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexesR Gavioli, Q J Zhang, M Marastoni, et al.Pageof 13